Greece Austerity Hits Patented Drugs, But Generics May Be Slow To Profit
This article was originally published in The Pink Sheet Daily
Executive Summary
The Greek government passed a series of measures aimed at cutting spending on patented medicines, but generics may only take off slowly as the country favors domestic firms.